Close
AI in Healthcare & Pharma Summit Boston 2026

FDA Approves Rasonque for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration (FDA) has approved Rasonque (daraxonrasib), a RAS inhibitor designed for the most common form of pancreatic cancer. The...

AI in Biosimilar Development Accelerating Comparability

The development of biosimilars is a high-stakes race against time, regulatory scrutiny, and the looming patent cliffs of blockbuster biologics. Unlike traditional generics, proving...

South Korea’s Big Five Pharma Firms Boost Research Funding

South Korea's domestic pharmaceutical companies are increasing their research and development (R&D) investments in 2026, directing overseas earnings toward new drug development and the...

Lonza Launches Custom Cell Culture Media Prototyping Service

Lonza has launched a rapid custom media prototyping service aimed at helping life sciences customers accelerate the early-stage development of cell culture media formulations....

TCS Launches AgentHub to Scale AI in Drug Development

Tata Consultancy Services has introduced TCS ADD™ AgentHub, a role-based, enterprise-ready, and trusted AI platform designed to support the use of agentic AI in...

AI-driven 3D Printing Accelerating Drug Development Pace

The landscape of pharmaceutical research and development is undergoing a seismic shift in 2026 as the synergy between artificial intelligence and additive manufacturing matures....

Turkish Pharma Sector R&D Spending Surges Over 8-Fold

Türkiye’s pharmaceutical sector has recorded significant growth in research activities, with overall R&D spending increasing 8.3 times between 2020 and 2024. According to a...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...